Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus
Clinical trial NCT02794285 · COMPLETED
Trial details
- NCT number
- NCT02794285
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-30
- Primary completion
- 2021-12-21
- Enrollment
- 559
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.